OABI
OmniAb, Inc.$1.41-0.04 (-2.43%)Prev Close$1.44·MCap$221.9M·P/E—·Vol242.8K·Yield—
▲
Buys (12M)
4
$283.4K
▼
Sells (12M)
12
$283.0K
◆
Net Activity
Net Buyer
$371.00
●
Active Insiders
6
last 12 mo
Over the past 12 months, insider activity at OmniAb, Inc. (OABI) has been mixed between buying and selling, with 4 insider purchases totaling $283.4K and 12 insider sales totaling $283.0K. The most recent insider transaction was by Berkman Charles S (officer: Chief Legal Officer), who sold $10.7K worth of shares on Apr 7, 2026. OmniAb, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $221.9M.
OABI Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Berkman Charles S | officer: Chief Legal Officer | Sell | 7,157 | $1.49 | $10.7K | 399,085 |
| Apr 7, 2026 | FOEHR MATTHEW W | director, officer: President and CEO | Sell | 19,244 | $1.49 | $28.7K | 4,420,492 |
| Apr 7, 2026 | GUSTAFSON KURT A | officer: Executive VP, Finance and CFO | Sell | 6,913 | $1.49 | $10.3K | 261,483 |
| Feb 18, 2026 | Berkman Charles S | Chief Legal Officer | Sell | 9,673 | $1.71 | $16.5K | 0 |
| Feb 18, 2026 | FOEHR MATTHEW W | President and CEO | Sell | 30,843 | $1.71 | $52.7K | 0 |
| Feb 18, 2026 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 9,301 | $1.71 | $15.9K | 0 |
| Feb 17, 2026 | Berkman Charles S | Chief Legal Officer | Sell | 6,990 | $1.70 | $11.9K | 0 |
| Feb 17, 2026 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 6,828 | $1.70 | $11.6K | 0 |
| Feb 16, 2026 | FOEHR MATTHEW W | President and CEO | Sell | 20,754 | $1.70 | $35.3K | 0 |
| Dec 9, 2025 | Berkman Charles S | Chief Legal Officer | Sell | 8,044 | $1.96 | $15.8K | 377,071 |
| Dec 9, 2025 | FOEHR MATTHEW W | President and CEO | Sell | 13,666 | $1.96 | $26.8K | 4,360,083 |
| Dec 9, 2025 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 23,922 | $1.96 | $46.9K | 252,688 |
| Nov 10, 2025 | HIGGINS JOHN L | Director | Buy | 77,261 | $1.39 | $107.7K | 2,929,148 |
| May 15, 2025 | Cochran Jennifer R. | Director | Buy | 30,000 | $1.52 | $45.6K | 145,274+26% |
| May 14, 2025 | Love Steven | Director | Buy | 25,000 | $1.46 | $36.5K | 38,333+188% |
| May 13, 2025 | HIGGINS JOHN L | Director | Buy | 65,000 | $1.44 | $93.6K | 2,831,887 |
| Apr 7, 2025 | Berkman Charles S | Chief Legal Officer | Sell | 7,206 | $2.00 | $14.4K | 363,212 |
| Apr 7, 2025 | FOEHR MATTHEW W | President and CEO | Sell | 19,382 | $2.00 | $38.8K | 3,796,236 |
| Apr 7, 2025 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 7,206 | $2.00 | $14.4K | 223,828 |
| Apr 1, 2025 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 11,963 | $2.37 | $28.4K | 217,492 |
| Mar 21, 2025 | HIGGINS JOHN L | Director | Buy | 4,000 | $2.28 | $9.1K | 2,766,887 |
| Mar 20, 2025 | HIGGINS JOHN L | Director | Buy | 125,750 | $2.35 | $295.5K | 2,762,887 |
| Feb 19, 2025 | Berkman Charles S | Chief Legal Officer | Sell | 15,470 | $3.68 | $56.9K | 364,131 |
| Feb 19, 2025 | FOEHR MATTHEW W | President and CEO | Sell | 33,486 | $3.67 | $123.0K | 3,798,682 |
| Feb 19, 2025 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 7,255 | $3.67 | $26.6K | 206,211 |
| Jan 22, 2025 | Berkman Charles S | Chief Legal Officer | Sell | 25,489 | $3.24 | $82.6K | 343,190 |
| Jan 22, 2025 | FOEHR MATTHEW W | President and CEO | Sell | 41,811 | $3.24 | $135.5K | 3,749,639 |
| Jan 22, 2025 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 15,526 | $3.24 | $50.3K | 212,720 |
| Dec 10, 2024 | Berkman Charles S | Chief Legal Officer | Sell | 8,022 | $4.13 | $33.1K | 323,385 |
| Dec 10, 2024 | FOEHR MATTHEW W | President and CEO | Sell | 13,634 | $4.13 | $56.3K | 3,714,447 |
| Dec 10, 2024 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 23,871 | $4.13 | $98.6K | 200,661 |
| May 28, 2024 | FOEHR MATTHEW W | President and CEO | Buy | 240,000 | $4.42 | $1.06M | 3,536,665 |
| Apr 9, 2024 | Berkman Charles S | Chief Legal Officer | Sell | 6,954 | $5.27 | $36.6K | 292,617 |
| Apr 9, 2024 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 6,954 | $5.27 | $36.6K | 176,697 |
| Apr 2, 2024 | GUSTAFSON KURT A | Executive VP, Finance & CFO | Sell | 11,849 | $5.46 | $64.7K | 170,110 |
| Mar 25, 2024 | FOEHR MATTHEW W | President and CEO | Buy | 225,000 | $5.19 | $1.17M | 2,908,803 |
| Dec 13, 2023 | FOEHR MATTHEW W | Chief Executive Officer | Buy | 200,000 | $5.05 | $1.01M | 2,645,442 |
| Nov 13, 2023 | FOEHR MATTHEW W | President and CEO | Buy | 95,000 | $4.27 | $405.5K | 2,427,919 |
| Aug 15, 2023 | FOEHR MATTHEW W | President and CEO | Buy | 45,000 | $5.48 | $246.6K | 2,332,919 |
| Jun 12, 2023 | FOEHR MATTHEW W | Chief Executive Officer | Buy | 115,000 | $4.52 | $519.8K | 2,574,009 |
| May 25, 2023 | HIGGINS JOHN L | Director | Sell | 9,000 | $4.05 | $36.5K | 2,462,686 |
| May 23, 2023 | HIGGINS JOHN L | Director | Sell | 1,000 | $4.05 | $4.0K | 2,462,686 |
| May 19, 2023 | HIGGINS JOHN L | Director | Sell | 50,000 | $3.89 | $194.5K | 2,462,686 |
| May 15, 2023 | FOEHR MATTHEW W | Chief Executive Officer | Buy | 440,000 | $3.40 | $1.50M | 2,438,414 |
OABI Insider Buying Activity
The following table shows recent insider purchases of OmniAb, Inc. (OABI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | HIGGINS JOHN L | Director | Buy | 77,261 | $1.39 | $107.7K | 2,929,148 |
| May 15, 2025 | Cochran Jennifer R. | Director | Buy | 30,000 | $1.52 | $45.6K | 145,274+26% |
| May 14, 2025 | Love Steven | Director | Buy | 25,000 | $1.46 | $36.5K | 38,333+188% |
| May 13, 2025 | HIGGINS JOHN L | Director | Buy | 65,000 | $1.44 | $93.6K | 2,831,887 |
| Mar 21, 2025 | HIGGINS JOHN L | Director | Buy | 4,000 | $2.28 | $9.1K | 2,766,887 |
| Mar 20, 2025 | HIGGINS JOHN L | Director | Buy | 125,750 | $2.35 | $295.5K | 2,762,887 |
| May 28, 2024 | FOEHR MATTHEW W | President and CEO | Buy | 240,000 | $4.42 | $1.06M | 3,536,665 |
| Mar 25, 2024 | FOEHR MATTHEW W | President and CEO | Buy | 225,000 | $5.19 | $1.17M | 2,908,803 |
| Dec 13, 2023 | FOEHR MATTHEW W | Chief Executive Officer | Buy | 200,000 | $5.05 | $1.01M | 2,645,442 |
| Nov 13, 2023 | FOEHR MATTHEW W | President and CEO | Buy | 95,000 | $4.27 | $405.5K | 2,427,919 |
| Aug 15, 2023 | FOEHR MATTHEW W | President and CEO | Buy | 45,000 | $5.48 | $246.6K | 2,332,919 |
| Jun 12, 2023 | FOEHR MATTHEW W | Chief Executive Officer | Buy | 115,000 | $4.52 | $519.8K | 2,574,009 |
| May 15, 2023 | FOEHR MATTHEW W | Chief Executive Officer | Buy | 440,000 | $3.40 | $1.50M | 2,438,414 |
OABI Insider Selling Activity
The following table shows recent insider sales of OmniAb, Inc. (OABI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Berkman Charles S | officer: Chief Legal Officer | Sell | 7,157 | $1.49 | $10.7K | 399,085 |
| Apr 7, 2026 | FOEHR MATTHEW W | director, officer: President and CEO | Sell | 19,244 | $1.49 | $28.7K | 4,420,492 |
| Apr 7, 2026 | GUSTAFSON KURT A | officer: Executive VP, Finance and CFO | Sell | 6,913 | $1.49 | $10.3K | 261,483 |
| Feb 18, 2026 | Berkman Charles S | Chief Legal Officer | Sell | 9,673 | $1.71 | $16.5K | 0 |
| Feb 18, 2026 | FOEHR MATTHEW W | President and CEO | Sell | 30,843 | $1.71 | $52.7K | 0 |
| Feb 18, 2026 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 9,301 | $1.71 | $15.9K | 0 |
| Feb 17, 2026 | Berkman Charles S | Chief Legal Officer | Sell | 6,990 | $1.70 | $11.9K | 0 |
| Feb 17, 2026 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 6,828 | $1.70 | $11.6K | 0 |
| Feb 16, 2026 | FOEHR MATTHEW W | President and CEO | Sell | 20,754 | $1.70 | $35.3K | 0 |
| Dec 9, 2025 | Berkman Charles S | Chief Legal Officer | Sell | 8,044 | $1.96 | $15.8K | 377,071 |
| Dec 9, 2025 | FOEHR MATTHEW W | President and CEO | Sell | 13,666 | $1.96 | $26.8K | 4,360,083 |
| Dec 9, 2025 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 23,922 | $1.96 | $46.9K | 252,688 |
| Apr 7, 2025 | Berkman Charles S | Chief Legal Officer | Sell | 7,206 | $2.00 | $14.4K | 363,212 |
| Apr 7, 2025 | FOEHR MATTHEW W | President and CEO | Sell | 19,382 | $2.00 | $38.8K | 3,796,236 |
| Apr 7, 2025 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 7,206 | $2.00 | $14.4K | 223,828 |
| Apr 1, 2025 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 11,963 | $2.37 | $28.4K | 217,492 |
| Feb 19, 2025 | Berkman Charles S | Chief Legal Officer | Sell | 15,470 | $3.68 | $56.9K | 364,131 |
| Feb 19, 2025 | FOEHR MATTHEW W | President and CEO | Sell | 33,486 | $3.67 | $123.0K | 3,798,682 |
| Feb 19, 2025 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 7,255 | $3.67 | $26.6K | 206,211 |
| Jan 22, 2025 | Berkman Charles S | Chief Legal Officer | Sell | 25,489 | $3.24 | $82.6K | 343,190 |
| Jan 22, 2025 | FOEHR MATTHEW W | President and CEO | Sell | 41,811 | $3.24 | $135.5K | 3,749,639 |
| Jan 22, 2025 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 15,526 | $3.24 | $50.3K | 212,720 |
| Dec 10, 2024 | Berkman Charles S | Chief Legal Officer | Sell | 8,022 | $4.13 | $33.1K | 323,385 |
| Dec 10, 2024 | FOEHR MATTHEW W | President and CEO | Sell | 13,634 | $4.13 | $56.3K | 3,714,447 |
| Dec 10, 2024 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 23,871 | $4.13 | $98.6K | 200,661 |
| Apr 9, 2024 | Berkman Charles S | Chief Legal Officer | Sell | 6,954 | $5.27 | $36.6K | 292,617 |
| Apr 9, 2024 | GUSTAFSON KURT A | Executive VP, Finance and CFO | Sell | 6,954 | $5.27 | $36.6K | 176,697 |
| Apr 2, 2024 | GUSTAFSON KURT A | Executive VP, Finance & CFO | Sell | 11,849 | $5.46 | $64.7K | 170,110 |
| May 25, 2023 | HIGGINS JOHN L | Director | Sell | 9,000 | $4.05 | $36.5K | 2,462,686 |
| May 23, 2023 | HIGGINS JOHN L | Director | Sell | 1,000 | $4.05 | $4.0K | 2,462,686 |
| May 19, 2023 | HIGGINS JOHN L | Director | Sell | 50,000 | $3.89 | $194.5K | 2,462,686 |
OABI Insiders
Similar Stocks to OABI
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B